Mediators of Inflammation / 2009 / Article / Tab 2

Clinical Study

Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinson's Disease

Table 2

Nitric oxide, growth hormone, insulin-like growth factor-1, and insulin-like growth factor BP-3 levels of the patients with PD and healthy controls.

PatientsControls

Nitric oxide ( ol/L)
mea D
Growth hormone (ng/mL)
mea D
Insulin-like growth factor-1 (ng/mL)
(mea D)
Insulin-like growth factor BP-3 ( /mL)
(mea D)

:.011, P:.52, P:.087, P:.19, respectively.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.